Zobrazeno 1 - 10
of 62
pro vyhledávání: '"P D, Mozley"'
Publikováno v:
International Journal of Biomedical Imaging, Vol 2011 (2011)
Background. This study presents a semiautomated approach for volumetric analysis of lung tumors and evaluates the feasibility of using volumes as an alternative to line lengths as a basis for response evaluation criteria in solid tumors (RECIST). The
Externí odkaz:
https://doaj.org/article/865ecd0f059949948ec8b6295ea22d0d
Autor:
Chantal Mahon, Terence G. Hamill, K Butterfield, Guy Bormans, John A. Wagner, Michel Koole, Fang Liu, J De Hoon, Richard Hargreaves, P Zappacosta, I De Lepeleire, P. D Mozley, Ruben Declercq, W Xie, Yang Liu, Inge Derdelinckx, K. Van Laere, M. G Murphy, Laura B. Rosen, Daniel Tatosian, Craig R. Shadle, S M Sanabria Bohorquez
Publikováno v:
Clinical Pharmacology & Therapeutics. 92:243-250
The type 1 neurokinin receptor (NK1R) antagonist aprepitant and its i.v. prodrug fosaprepitant have been approved for prevention of acute and delayed nausea and vomiting associated with chemotherapy. This study evaluated the magnitude and duration of
Autor:
Andrew B. Newberg, Andrew Siderowf, Howard I. Hurtig, P. D. Mozley, M.B. Stern, Bernard Ravina, Kelvin L. Chou, Amy Colcher
Publikováno v:
Parkinsonism & Related Disorders. 10:375-379
We evaluated the diagnostic accuracy of SPECT imaging using [ 99m Tc]TRODAT-1 (TRODAT), a relatively inexpensive technetiumlabeled dopamine transporter ligand, in distinguishing 29 patients with early PD from 38 healthy volunteers. Mean TRODAT uptake
Autor:
P D Mozley, P D Acton
Publikováno v:
Behavioural Neurology, Vol 12, Iss 1-2, Pp 11-27 (2000)
Parkinsonian symptoms are associated with a number of neurodegenerative disorders, such as Parkinson’s disease, multiple system atrophy and progressive supranuclear palsy. Pathological evidence has shown clearly that these disorders are associated
Publikováno v:
American Journal of Psychiatry. 155:1711-1717
Objective:This study examined whether subcortical volumes of the basal ganglia and thalamus in schizophrenic patients are related to neuroleptic exposure and symptom severity. Method:Basal ganglia substructures and thalamic volumes were measured with
Autor:
Bunow Bj, Stecker Mh, Abass Alavi, P D Mozley, Muenz Lr, Andrew B. Newberg, Hee Joung Kim, Sadek Am, Ruben C. Gur, Jolles P
Publikováno v:
European Journal of Nuclear Medicine. 24:754-761
Some brain functions decline at a linear rate throughout adulthood. Others remain relatively stable until very late in the life cycle. This study characterized the effects of aging on the regional cerebral distribution of hexamethylpropylene amine ox
Publikováno v:
Biological Psychiatry. 40:443-451
Quantitative resting fluorodeoxyglucose-positron emission tomography scans were performed on 42 patients with schizophrenia. Magnetic resonance imaging-based regions of interest were transposed onto the corresponding positron emission tomography imag
Autor:
Fiona Gallacher, Ruben C. Gur, Bruce I. Turetsky, Raquel E. Gur, P D Mozley, Robert I. Grossman, Tyrone D. Cannon, Derri L. Shtasel
Publikováno v:
American Journal of Psychiatry. 151:343-350
OBJECTIVE Investigations of the relation of clinical features of schizophrenia to neuroanatomic measures have produced inconclusive results. The purpose of this study was to examine measures of whole-brain volume in men and women and relate them to c
Publikováno v:
International Journal of Biomedical Imaging, Vol 2011 (2011)
International Journal of Biomedical Imaging
International Journal of Biomedical Imaging
Background. This study presents a semiautomated approach for volumetric analysis of lung tumors and evaluates the feasibility of using volumes as an alternative to line lengths as a basis for response evaluation criteria in solid tumors (RECIST). The
Autor:
Anthony P. Reeves, Binsheng Zhao, Ricardo Scott Avila, Michael F. McNitt-Gray, P. D. Mozley, Nicholas Petrick, Lawrence H. Schwartz, Andrew J. Buckler, Charles Fenimore
Publikováno v:
Optics express. 18(14)
The drug development industry is faced with increasing costs and decreasing success rates. New ways to understand biology as well as the increasing interest in personalized treatments for smaller patient segments requires new capabilities for the rap